VCRC Tissue Repository
Study Details
Study Description
Brief Summary
The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Biopsy specimens collected as standard of care for these diseases will be retrieved and used in research. The most common biopsies performed are kidney, lung, skin, nerves, and vessels; however, other tissue is also of interest for the study. Biopsies are not performed as part of this protocol, rather we will request consent to collect biopsy specimens already collected under routine care.
Study Design
Outcome Measures
Primary Outcome Measures
- Identify genes that increase the risk of developing vasculitis [1 year]
Evaluating of clinical data and linked biopsy specimens to identify genes that increase the risk of developing vasculitis.
Eligibility Criteria
Criteria
Inclusion Criteria:
- A participant will be deemed eligible for this study if the participant is/was enrolled in another one of the VCRC observational/longitudinal protocols (5502, 5503, 5504, 5505, 5506, 5507, 5563) and/or one of the VCRC interventional studies (5522, 5523, 5526, 5527, or 5562).
Exclusion Criteria:
-
Inability to give informed consent (or their guardians in the case of children) and to sign the consent form.
-
Unwilling to allow the use of their tissue for research.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Brigham and Women's Hospital | Boston | Massachusetts | United States | 02115 |
2 | Boston University School of Medicine | Boston | Massachusetts | United States | 02118 |
3 | Cleveland Clinic | Cleveland | Ohio | United States | 44195 |
4 | University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104 |
5 | University of Pittsburgh | Pittsburgh | Pennsylvania | United States | 15261 |
6 | University of Utah | Salt Lake City | Utah | United States | 84132 |
7 | St. Joseph's Healthcare | Hamilton | Ontario | Canada | L8N 3B6 |
8 | University of Toronto Mount Sinai Hospital | Toronto | Ontario | Canada | M5G 1X5 |
Sponsors and Collaborators
- University of Pennsylvania
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Center for Advancing Translational Science (NCATS)
- Office of Rare Diseases (ORD)
Investigators
- Study Chair: Peter A Merkel, MD, MPH, University of Pennsylvania
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- VCRC5511
- U54AR057319